|Bid||288,777.00 x 0|
|Ask||302,000.00 x 0|
|Day's Range||291,221.50 - 294,110.00|
|52 Week Range||246,520.00 - 326,350.00|
|PE Ratio (TTM)||10.68|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||348,875.00|
Millennials are leaving their mark on corporate culture. Yahoo Finance’s Alexis Christoforous, Andy Serwer, and Julia La Roche discuss whether these trends are happening in all sectors.
You might not be aware of it, but big pharma stocks have gone through a difficult period for many years. A lot of the big drugs at the big pharma stocks went off patent, and the revenue for some of the big pharma stocks has fallen off as a result. Some of the big pharma stocks were able to replace that revenue and some weren’t.
As noted previously, US-China trade war fears have subsided for the time being after the second round of talks held last week. Financial markets breathed a sigh of relief after the US-China trade war was put on hold. Broader market indexes like the S&P 500 (SPY) closed with gains on May 21 after constructive trade talks between the world’s two biggest economies. Notably, during the annual shareholder meeting, Warren Buffett, Berkshire Hathaway’s (BRK-B) chair, also expressed optimism about US-China trade relations. ...
At least nine newsroom staffers from the Buffalo News’ newsroom have accepted buyout offers from the paper as it continues to deal with economic factors impacting media outlets, particularly newspapers, across the country. The actions are part of a financial belt-tightening instituted by the Buffalo News, which is owned by Berkshire Hathaway Inc. “There were buyout offers made,” confirmed Sandra Tan, a News reporter and current Buffalo Newspaper Guild CWA Local 31026 president. Sources said among those accepting the buyouts include sports reporter John Vogl, who has covered the Buffalo Sabres for the past 16 years, and health care reporter Henry Davis, a past Buffalo Newspaper Guild CWA Local 31026 president.
Two stocks the world's best-known investor recently added to, and a little-known biotech getting the backing of a little-known (but very successful) pair of biopharma investors.
As the head of a vast business empire and the richest person on earth, Amazon Chief Executive Jeff Bezos may well come to mind as an obvious idol for many budding entrepreneurs. Bezos was asked that question at a panel held last month at Southern Methodist University, and took the opportunity to shower some praise on JPMorgan Chase(JPM)CEO Jamie Dimon. “If I were a big shareholder in JPMorgan Chase, I would just show up every Monday morning with, like, pastries and coffee for Jamie,” Bezos said during the Forum on Leadership panel.
While Teva Pharmaceutical Industries Ltd (ADR) ADR (NYSE:TEVA) faded from last Wednesday highs, shares ultimately climbed about 3% that day. No, it wasn’t earnings or a new drug that gave TEVA stock a bump. Instead, it was Warren Buffett.
As of Monday, credit analysts at Moody’s Investors Service were just beginning to feel optimistic about the packaged-food giant. Since the 2015 merger that brought together Kraft Foods and H.J. Heinz, the company’s private equity managers have extracted more cost savings than expected and retired some debt. Now, with the merger integration largely complete, Moody’s changed its outlook to positive from stable, saying it expects Kraft Heinz’s debt-to-Ebitda ratio to fall “sustainably below” 4 this year, down from 5.2 when the deal first closed.
HomeServices of America plans to make the Dallas real estate firm a statewide brand.
From the time he was in business school, Ted Weschler followed Warren Buffett's investing philosophies and became a success. Then, Buffett hired Weschler to making investing decisions at Berkshire Hathaway in 2011 after meeting him at The Glide Foundation charity lunches.